Literature DB >> 2258424

High-performance liquid chromatography of antibiotics.

F Jehl1, C Gallion, H Monteil.   

Abstract

High-performance liquid chromatographic (HPLC) monitoring of antimicrobial agents has recently become more widely used, and represents an interesting alternative to other methods. The methodology is characterized by good specificity and accuracy, and it is applicable to almost all antibiotics. This review first describes the successive steps to investigate for the development of an HPLC method for a new antibiotic, and how to make use of it. Particular emphasis is put on the problems related to the standardization of sample preparation and to the development of mobile phases for use with different molecules belonging to the same class. The second part of the review describes one or more HPLC techniques for a representative antibiotic of each major class.

Mesh:

Substances:

Year:  1990        PMID: 2258424     DOI: 10.1016/s0378-4347(00)82293-8

Source DB:  PubMed          Journal:  J Chromatogr


  21 in total

1.  Assessment of biliary excretion of piperacillin-tazobactam in humans.

Authors:  J F Westphal; J M Brogard; F Caro-Sampara; M Adloff; J F Blicklé; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.

Authors:  F Jehl; C Muller-Serieys; V de Larminat; H Monteil; E Bergogne-Berezin
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

3.  Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.

Authors:  O Mimoz; A Jacolot; S Leotard; N Hidri; K Samii; P Nordmann; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

4.  Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs.

Authors:  A Cavalier; D Levêque; J D Peter; J Salmon; H Elkhaïli; Y Salmon; P Nobelis; J Geisert; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.

Authors:  Elisabeth Aslangul; Raymond Ruimy; Françoise Chau; Louis Garry; Antoine Andremont; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

Authors:  A Saleh Mghir; A C Crémieux; R Bleton; F Ismael; M Manteau; S Dautrey; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Biliary excretion of cefixime: assessment in patients provided with T-tube drainage.

Authors:  J F Westphal; F Jehl; M Schloegel; H Monteil; J M Brogard
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

8.  Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.

Authors:  H Carsenti-Etesse; R Farinotti; J Durant; P M Roger; F De Salvador; E Bernard; B Rouveix; P Dellamonica
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

9.  Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection.

Authors:  Farid Ismael; Rémy Bléton; Azzam Saleh-Mghir; Sophie Dautrey; Laurent Massias; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.

Authors:  J L Fournier; F Ramisse; A C Jacolot; M Szatanik; O J Petitjean; J M Alonso; M R Scavizzi
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.